Prestige Consumer Healthcare Inc. (NYSE:PBH) Shares Bought by Barclays PLC

Barclays PLC lifted its stake in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 20.8% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 111,689 shares of the company's stock after buying an additional 19,245 shares during the period. Barclays PLC owned approximately 0.23% of Prestige Consumer Healthcare worth $8,721,000 at the end of the most recent quarter.

Several other hedge funds have also recently made changes to their positions in the company. Raymond James Financial Inc. purchased a new stake in Prestige Consumer Healthcare during the 4th quarter valued at about $42,593,000. Norges Bank purchased a new stake in Prestige Consumer Healthcare in the fourth quarter valued at approximately $40,009,000. Bessemer Group Inc. increased its holdings in Prestige Consumer Healthcare by 10,053.1% in the 4th quarter. Bessemer Group Inc. now owns 295,050 shares of the company's stock worth $23,041,000 after buying an additional 292,144 shares during the period. Boston Trust Walden Corp raised its position in Prestige Consumer Healthcare by 43.5% during the 4th quarter. Boston Trust Walden Corp now owns 831,627 shares of the company's stock worth $64,942,000 after buying an additional 252,089 shares during the last quarter. Finally, Natixis Advisors LLC lifted its stake in Prestige Consumer Healthcare by 1,335.1% during the 4th quarter. Natixis Advisors LLC now owns 209,246 shares of the company's stock valued at $16,340,000 after acquiring an additional 194,665 shares during the period. 99.95% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of research firms recently issued reports on PBH. Oppenheimer boosted their target price on shares of Prestige Consumer Healthcare from $87.00 to $93.00 and gave the company an "outperform" rating in a research report on Thursday, February 13th. StockNews.com cut Prestige Consumer Healthcare from a "buy" rating to a "hold" rating in a research report on Tuesday, April 8th. Canaccord Genuity Group upped their price objective on Prestige Consumer Healthcare from $93.00 to $100.00 and gave the stock a "buy" rating in a research report on Friday, February 7th. Royal Bank of Canada lifted their target price on shares of Prestige Consumer Healthcare from $96.00 to $97.00 and gave the company a "sector perform" rating in a report on Friday, March 21st. Finally, DA Davidson raised their price target on shares of Prestige Consumer Healthcare from $95.00 to $104.00 and gave the company a "buy" rating in a research report on Friday, February 7th. Four research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to MarketBeat.com, the company has an average rating of "Hold" and an average target price of $93.33.

Prestige Consumer Healthcare Price Performance

NYSE PBH traded up $0.72 on Tuesday, hitting $81.67. The company had a trading volume of 24,335 shares, compared to its average volume of 286,779. The company has a debt-to-equity ratio of 0.56, a current ratio of 3.68 and a quick ratio of 2.20. The company has a market capitalization of $4.05 billion, a PE ratio of 19.12, a PEG ratio of 2.69 and a beta of 0.47. Prestige Consumer Healthcare Inc. has a 12-month low of $62.35 and a 12-month high of $90.04. The company's fifty day moving average price is $83.52 and its 200-day moving average price is $80.73.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last issued its quarterly earnings results on Thursday, February 6th. The company reported $1.22 earnings per share for the quarter, beating analysts' consensus estimates of $1.18 by $0.04. Prestige Consumer Healthcare had a net margin of 19.13% and a return on equity of 12.36%. As a group, analysts predict that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current year.

Insider Activity at Prestige Consumer Healthcare

In other Prestige Consumer Healthcare news, SVP Mary Beth Fritz sold 1,678 shares of the firm's stock in a transaction that occurred on Monday, March 10th. The shares were sold at an average price of $90.00, for a total value of $151,020.00. Following the transaction, the senior vice president now directly owns 17,157 shares of the company's stock, valued at $1,544,130. This trade represents a 8.91 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 1.60% of the stock is owned by corporate insiders.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.